NCT01092182 2023-04-27Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell LymphomaNational Institutes of Health Clinical Center (CC)Phase 2 Completed194 enrolled 19 charts